Latest Articles
Sumona Chakravarti on Endometriosis, Fitness and Finding Balance | Grazia India - Grazia India
Sumona Chakravarti on Endometriosis, Fitness and Finding Balance | Grazia India Grazia India
Published: Sept. 11, 2025, 11:08 a.m.
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at - The Times of India
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at The Times of India
Published: Aug. 31, 2025, 8:32 a.m.
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at - Times of India
Karnataka: Woman treated for severe endometriosis, pelvic abscess & sepsis managed; successful surgery at Times of India
Published: Aug. 31, 2025, 8:32 a.m.
Severe period pain could signal endometriosis, say experts - The Hans India
Severe period pain could signal endometriosis, say experts The Hans India
Published: Aug. 31, 2025, 7 a.m.
GSK enters Indian oncology market with gynaecological cancer drugs - MSN
GSK enters Indian oncology market with gynaecological cancer drugs MSN
Published: Aug. 28, 2025, 8:16 a.m.
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure - The Times of India
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure The Times of India
Published: Aug. 27, 2025, 8:16 a.m.
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure - Times of India
Can AI outsmart superbugs? MIT’s new antibiotics offer hope for cure Times of India
Published: Aug. 27, 2025, 1 a.m.
Don’t normalise period pain: Endometriosis cases rising in India - Times of India
Don’t normalise period pain: Endometriosis cases rising in India Times of India
Published: Aug. 27, 2025, 12:30 a.m.
Don’t normalise period pain: Endometriosis cases rising in India - The Times of India
Don’t normalise period pain: Endometriosis cases rising in India The Times of India
Published: Aug. 27, 2025, 12:30 a.m.
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? - MSN
Why Jemperli and Zejula will be key assets in GSK's India oncology portfolio? MSN
Published: Aug. 26, 2025, 12:50 p.m.
Link copied to clipboard!